Taiwan Liposome Ltd.

NASDAQ: TLC · Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Revenue by Geography

Period Ending Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
China Revenue 56.83M 142.84M 52.1M
China Revenue Growth -60.21% +174.17% n/a
Others Revenue 5.62M 7.33M n/a
Others Revenue Growth -23.40% n/a n/a
Taiwan, Province Of China Revenue 39.48M 58.97M n/a
Taiwan, Province Of China Revenue Growth -33.05% n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 31.62M 31.05M 35.24M 38.17M 39.49M 32.88M n/a n/a 38.13M 40.78M 45.61M 34.37M 33.85M 33.91M 37.48M 41.24M 27.05M 29.1M 33.71M 41.9M 28.25M 37.63M 31.43M 34.53M 40.05M 32.3M
Selling, General, and Administrative Revenue Growth +1.85% -11.89% -7.68% -3.35% +20.09% n/a n/a -100.00% -6.50% -10.60% +32.72% +1.52% -0.17% -9.53% -9.12% +52.45% -7.03% -13.69% -19.54% +48.30% -24.92% +19.71% -8.97% -13.78% +23.98% n/a
Research and Development Revenue 220.09M 222.77M 275.3M 271.54M 228.88M 191.78M 249.15M 157.9M 224.22M 229.16M 281.18M 184.56M 215.74M 151.1M 248.61M 204.06M 213.59M 146.99M 250.04M 207.49M 136.48M 142.88M 133.5M 171.46M 175.32M 154.56M
Research and Development Revenue Growth -1.21% -19.08% +1.39% +18.64% +19.35% -23.03% +57.79% -29.58% -2.15% -18.50% +52.35% -14.45% +42.77% -39.22% +21.83% -4.46% +45.31% -41.21% +20.51% +52.03% -4.48% +7.02% -22.14% -2.20% +13.43% n/a